British MPs and peers urge Chancellor to support the life sciences in Budget

17 October 2024

A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30.

The call comes from the newly-formed All-Party Parliamentary Group (APPG) for Life Sciences, which held its first meeting in Parliament on Tuesday to discuss what the Labour government must do to ensure the UK remains a powerhouse for life sciences research and commercialisation.

Writing to the Chancellor after the meeting, they welcomed the Labour Party's plan for life sciences published ahead of the general election, called A prescription for growth, and urged the Chancellor to protect government funding for life sciences research and manufacturing, and the tax reliefs that encourage investment, in the Budget on 30 October.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical